Gervasi, Noreen M.
Dimtchev, Alexander
Clark, Desraj M.
Dingle, Marvin
Pisarchik, Alexander V.
Nesti, Leon J.
Funding for this research was provided by:
National Institutes of Health (1 R43 NS110112-01)
Article History
Received: 24 November 2020
Accepted: 4 May 2021
First Online: 14 July 2021
Competing interests
: AP is COO and Program Director of Alcamena Stem Cell Therapeutics. NMG is Director of Neurological Drug Development at Alcamena Stem Cell Therapeutics.